奥美拉唑与瑞巴派特治疗药物性胃病比较
【中图分类号】R573【文献标识码】D【文章编号】1672-5085(2008)02-0136-01【摘要】目的:评价质子泵抑制剂(PPI)及胃黏膜保护剂治疗NSAIDs所致药物性胃病的临床疗效。方法:分析120例因服NSAIDs引起消化系统症状的病例资料给予质子泵抑制剂(PPI)及胃黏膜保护剂瑞巴派特治疗效果。结果:质子泵抑制剂及胃黏膜保护剂瑞巴派特有明显疗效，其中PPI优于后者。结论:质子泵抑制剂(PPI) 治疗NSAIDs所致药物性胃病疗效显著。
【关键词】非甾体抗炎药；药物性胃病；质子泵抑制剂；胃黏膜保护剂
The Austria America pulls sends with the Swiss Pakistan especially to treat the medicine gastric disease to compare Lv Hongbo Zhang Guixia Li Yumei
【Abstract】Objective:The appraisal proton pumps the inhibitor (PPI) and the stomach mucous membrane protecting agent treats NSAIDs to be the result of the medicine gastric disease clinical curative effect. Method: Analyzes 120 examples because to take NSAIDs to cause the digesting system symptom case of illness material to give the proton to pump the inhibitor (PPI) and the stomach mucous membrane protecting agent Switzerland Pakistan sends the especially treatment result. Result：The proton pumps the inhibitor and the stomach mucous membrane protecting agent Switzerland Pakistan sends the unique obvious curative effect, PPI surpasses latter. Conclusion: The proton pumps the inhibitor (PPI) to treat NSAIDs to be the result of the medicine gastric disease curative effect to be remarkable. ......
您现在查看是摘要页，全文长 4900 字符。